Persistent Oral Mucosal Lesions Preceding Diagnosis of Crohn's Disease and Primary Sclerosing Cholangitis

Overview

Journal Clin Case Rep

Date 2023 May 14

PMID 37180315

Authors

Karita Nylund

Jaana Helenius-Hietala

Fredrik Aberg

Jaana Hagstrom

Hellevi Ruokonen

Affiliations

Soon will be listed here.

Abstract

Oral mucosal lesions may persist years before symptoms or diagnosis of inflammatory bowel disease (IBD) and subsequent primary sclerosing cholangitis (PSC). Since a dental practitioner may be the first clinician to suspect IBD with extraintestinal manifestations (EIMs), early referral, and close collaboration with a gastroenterologist are recommended.

Citing Articles

Persistent oral mucosal lesions preceding diagnosis of Crohn's disease and primary sclerosing cholangitis.

Nylund K, Helenius-Hietala J, Aberg F, Hagstrom J, Ruokonen H Clin Case Rep. 2023; 11(5):e07226.

PMID: 37180315 PMC: 10172456. DOI: 10.1002/ccr3.7226.

References

Woo V . Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature. Case Rep Dent. 2015; 2015:830472. PMC: 4512596. DOI: 10.1155/2015/830472. View

Sircus W, Church R, Kelleher J . Recurrent aphthous ulceration of the mouth; a study of the natural history, aetiology, and treatment. Q J Med. 1957; 26(102):235-49. View

Rogler G, Singh A, Kavanaugh A, Rubin D . Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021; 161(4):1118-1132. PMC: 8564770. DOI: 10.1053/j.gastro.2021.07.042. View

Nylund K, Helenius-Hietala J, Aberg F, Hagstrom J, Ruokonen H . Persistent oral mucosal lesions preceding diagnosis of Crohn's disease and primary sclerosing cholangitis. Clin Case Rep. 2023; 11(5):e07226. PMC: 10172456. DOI: 10.1002/ccr3.7226. View

Zippi M, Corrado C, Pica R, Avallone E, Cassieri C, De Nitto D . Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014; 20(46):17463-7. PMC: 4265606. DOI: 10.3748/wjg.v20.i46.17463. View

Philpot H, Elewski B, Banwell J, Gramlich T . Pyostomatitis vegetans and primary sclerosing cholangitis: markers of inflammatory bowel disease. Gastroenterology. 1992; 103(2):668-74. DOI: 10.1016/0016-5085(92)90863-t. View

Alawi F, Shields B, Omolehinwa T, Rosenbach M . Oral Granulomatous Disease. Dermatol Clin. 2020; 38(4):429-439. DOI: 10.1016/j.det.2020.05.004. View

Mays J, Sarmadi M, Moutsopoulos N . Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. J Evid Based Dent Pract. 2012; 12(3 Suppl):265-82. DOI: 10.1016/S1532-3382(12)70051-9. View

Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778. DOI: 10.1016/S0140-6736(17)32448-0. View

10.

Rikardsson S, Jonsson J, Hultin M, Gustafsson A, Johannsen A . Perceived oral health in patients with Crohn's disease. Oral Health Prev Dent. 2009; 7(3):277-82. View

11.

Lauritano D, Boccalari E, Di Stasio D, Della Vella F, Carinci F, Lucchese A . Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review. Diagnostics (Basel). 2019; 9(3). PMC: 6787704. DOI: 10.3390/diagnostics9030077. View

12.

Ott C, Scholmerich J . Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013; 10(10):585-95. DOI: 10.1038/nrgastro.2013.117. View

13.

Laranjeira N, Fonseca J, Meira T, Freitas J, Valido S, Leitao J . Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients. Arq Gastroenterol. 2015; 52(2):105-10. DOI: 10.1590/S0004-28032015000200006. View

14.

Zhao M, Gonczi L, Lakatos P, Burisch J . The Burden of Inflammatory Bowel Disease in Europe in 2020. J Crohns Colitis. 2021; 15(9):1573-1587. DOI: 10.1093/ecco-jcc/jjab029. View

15.

Muhvic-Urek M, Tomac-Stojmenovic M, Mijandrusic-Sincic B . Oral pathology in inflammatory bowel disease. World J Gastroenterol. 2016; 22(25):5655-67. PMC: 4932203. DOI: 10.3748/wjg.v22.i25.5655. View

16.

Rowland M, Fleming P, Bourke B . Looking in the mouth for Crohn's disease. Inflamm Bowel Dis. 2009; 16(2):332-7. DOI: 10.1002/ibd.20983. View

17.

Byrd K, Gulati A . The "Gum-Gut" Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances. Front Immunol. 2021; 12:620124. PMC: 7933581. DOI: 10.3389/fimmu.2021.620124. View

18.

Nijakowski K, Gruszczynski D, Surdacka A . Oral Health Status in Patients with Inflammatory Bowel Diseases: A Systematic Review. Int J Environ Res Public Health. 2021; 18(21). PMC: 8582688. DOI: 10.3390/ijerph182111521. View